{"id":19060,"date":"2022-09-19T20:09:38","date_gmt":"2022-09-19T23:09:38","guid":{"rendered":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/"},"modified":"2022-09-19T20:09:38","modified_gmt":"2022-09-19T23:09:38","slug":"56021927pcr3015-primordium-cancer-de-prostata","status":"publish","type":"ensaio_clinico","link":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/","title":{"rendered":"56021927PCR3015 PRIMORDIUM &#8211; C\u00e2ncer de pr\u00f3stata"},"content":{"rendered":"<p><strong>56021927PCR3015 PRIMORDIUM<\/strong><\/p>\n<p>Estudo randomizado, controlado, multic\u00eantrico e aberto para investigar a efic\u00e1cia e a seguran\u00e7a da adi\u00e7\u00e3o de apalutamida \u00e0 radioterapia e agonista de LHRH em participantes da pesquisa em alto risco com c\u00e2ncer de pr\u00f3stata PSMA-PET- positivo e horm\u00f4nio-sens\u00edvel com um acompanhamento observacional de participantes da pesquisa PSMA-PET-negativos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>56021927PCR3015 PRIMORDIUM Estudo randomizado, controlado, multic\u00eantrico e aberto para investigar a efic\u00e1cia e a seguran\u00e7a da adi\u00e7\u00e3o de apalutamida \u00e0 radioterapia e agonista de LHRH em participantes da pesquisa em alto risco com c\u00e2ncer de pr\u00f3stata PSMA-PET- positivo e horm\u00f4nio-sens\u00edvel com um acompanhamento observacional de participantes da pesquisa PSMA-PET-negativos.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-19060","ensaio_clinico","type-ensaio_clinico","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>56021927PCR3015 PRIMORDIUM - C\u00e2ncer de pr\u00f3stata - IDOR - Instituto D&#039;Or de Pesquisa e Ensino<\/title>\n<link rel=\"canonical\" href=\"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"56021927PCR3015 PRIMORDIUM - C\u00e2ncer de pr\u00f3stata - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta property=\"og:description\" content=\"56021927PCR3015 PRIMORDIUM Estudo randomizado, controlado, multic\u00eantrico e aberto para investigar a efic\u00e1cia e a seguran\u00e7a da adi\u00e7\u00e3o de apalutamida \u00e0 radioterapia e agonista de LHRH em participantes da pesquisa em alto risco com c\u00e2ncer de pr\u00f3stata PSMA-PET- positivo e horm\u00f4nio-sens\u00edvel com um acompanhamento observacional de participantes da pesquisa PSMA-PET-negativos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/\" \/>\n<meta property=\"og:site_name\" content=\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/pesquisa\\\/ensaiosclinicos\\\/56021927pcr3015-primordium-cancer-de-prostata\\\/\",\"url\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/pesquisa\\\/ensaiosclinicos\\\/56021927pcr3015-primordium-cancer-de-prostata\\\/\",\"name\":\"56021927PCR3015 PRIMORDIUM - C\u00e2ncer de pr\u00f3stata - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/#website\"},\"datePublished\":\"2022-09-19T23:09:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/pesquisa\\\/ensaiosclinicos\\\/56021927pcr3015-primordium-cancer-de-prostata\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/pesquisa\\\/ensaiosclinicos\\\/56021927pcr3015-primordium-cancer-de-prostata\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rededorsaoluiz.com.br\\\/instituto\\\/idor\\\/pesquisa\\\/ensaiosclinicos\\\/56021927pcr3015-primordium-cancer-de-prostata\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensaios Cl\u00ednicos\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"56021927PCR3015 PRIMORDIUM &#8211; C\u00e2ncer de pr\u00f3stata\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/#website\",\"url\":\"https:\\\/\\\/ptbr.idor.org\\\/\",\"name\":\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ptbr.idor.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"56021927PCR3015 PRIMORDIUM - C\u00e2ncer de pr\u00f3stata - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","canonical":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/","og_locale":"pt_BR","og_type":"article","og_title":"56021927PCR3015 PRIMORDIUM - C\u00e2ncer de pr\u00f3stata - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","og_description":"56021927PCR3015 PRIMORDIUM Estudo randomizado, controlado, multic\u00eantrico e aberto para investigar a efic\u00e1cia e a seguran\u00e7a da adi\u00e7\u00e3o de apalutamida \u00e0 radioterapia e agonista de LHRH em participantes da pesquisa em alto risco com c\u00e2ncer de pr\u00f3stata PSMA-PET- positivo e horm\u00f4nio-sens\u00edvel com um acompanhamento observacional de participantes da pesquisa PSMA-PET-negativos.","og_url":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/","og_site_name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/","url":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/","name":"56021927PCR3015 PRIMORDIUM - C\u00e2ncer de pr\u00f3stata - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","isPartOf":{"@id":"https:\/\/ptbr.idor.org\/#website"},"datePublished":"2022-09-19T23:09:38+00:00","breadcrumb":{"@id":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/56021927pcr3015-primordium-cancer-de-prostata\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ptbr.idor.org\/"},{"@type":"ListItem","position":2,"name":"Ensaios Cl\u00ednicos","item":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/"},{"@type":"ListItem","position":3,"name":"56021927PCR3015 PRIMORDIUM &#8211; C\u00e2ncer de pr\u00f3stata"}]},{"@type":"WebSite","@id":"https:\/\/ptbr.idor.org\/#website","url":"https:\/\/ptbr.idor.org\/","name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ptbr.idor.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico\/19060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico"}],"about":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/types\/ensaio_clinico"}],"wp:attachment":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/media?parent=19060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}